GlassScriptPhysician profile
Barry C Malloy
NPI 1184604845
$2,177.84
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $58.92 · 2021: $44.28 · 2022: $270 · 2023: $761 · 2024: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521 · Education: $40.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.49 |
| Education | $40.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $598.03 | 2019-2024 | Eylea Hd, Eylea |
| Abbvie INC. | $588.29 | 2022-2024 | |
| Genentech USA, INC. | $346.32 | 2019-2024 | Vabysmo |
| Coherus Oncology, INC. | $120.39 | 2022-2024 | |
| Alcon Vision LLC | $67.16 | 2022-2024 | Hydrus Microstent, Rocklatan |
| Alimera Sciences, INC. | $65.19 | 2023-2024 | Yutiq, Iluvien |
| Bausch & Lomb Americas INC. | $61.74 | 2022-2024 | Xipere, Visudyne |
| Apellis Pharmaceuticals, INC. | $41.95 | 2023-2024 | Syfovre |
| Astellas Pharma US INC | $39.91 | 2023-2024 | Izervay |
| Oyster Point Pharma, INC. | $38.00 | 2022-2023 | Tyrvaya |
| Merz North America, INC. | $34.38 | 2019 | |
| Sandoz INC. | $23.56 | 2024 | Cimerli |
| Rayner Intraocular Lenses Limited | $19.15 | 2023 | Rayone Aspheric, Rayone Emv, Omidria |
| Kala Pharmaceuticals, INC. | $18.21 | 2019 | |
| Dompe US, INC. | $17.39 | 2024 | Oxervate |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Aerie Pharmaceuticals, INC. | $16.00 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.40 | 2023 | Cequa |
| Ani Pharmaceuticals, INC. | $13.37 | 2024 | Purified Cortrophin Gel |
| Allergan, INC. | $13.19 | 2021 | |
| Shire North American Group INC | $12.89 | 2019 | |
| Vyera Pharmaceuticals, LLC | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Malloy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.